Latest videos

All news posts

Enorama Pharma enters into an agreement with Twinroll Service AB on international sales of tobacco-free nicotine pouches

Enorama Pharma AB (publ) ("Enorama Pharma" or "the Company") has entered into an agreement ("the Agreement") with Twinroll Service AB ("Twinroll") on international sales of the Company's tobacco-free nicotine pouches “All White”.

 

The agreement regulates the Company's and...

Enorama Pharma's license for import and handling of cannabis is approved and extended

Licenses to be allowed to handle cannabis in development work are issued by the Swedish Medical Products Agency, which ensures that the company's import and handling is in accordance with current legislation. Permits to import and handle cannabis should be renewed every year and...

Enorama Pharma enters into license and supply agreement regarding sale of nicotine chewing gum in Germany with betapharm Arzneimittel GmbH

Enorama Pharma AB (publ) (”Enorama Pharma” or ” the Company”) has entered into a license and supply agreement with betapharm Arzneimittel GmbH (”betapharm”) regarding sale of the Company’s nicotine chewing gum in Germany.


As previously communicated, Enorama Pharma and betapharm...

The MRP process for Enorama Pharma's nicotine chewing gum is completed

On May 5, 2020, Enorama Pharma AB (publ) ("Enorama Pharma" or "The Company") was informed by the Swedish Medical Products Agency that the Company's MRP application has passed the final phase, which is called "End of Procedure". All seven EU member states in which the application...

Enorama Pharma's wholesale license is approved and extended

In 2018, Enorama Pharma obtained a wholesale license. Wholesale licenses are issued by the Swedish Medical Products Agency, which ensures that the company complies with the applicable Good Distribution Practice (GDP) rules. To get the license extended, the Swedish Medical...

Enorama Pharma secures financing through loan agreements of 17 million SEK and refinances existing loans of 18 million SEK with Swede Unipharma AB

The Board of Directors of Enorama Pharma AB (publ) ("Enorama Pharma" or "the Company") announces that the Company has entered into a loan agreement with the Company's principal owner Swede Unipharma AB and increases the Company's loan to a total of approximately 35 million SEK....

Enorama Pharma receives its second order for tobacco-free nicotine pouches

Enorama Pharma announces that the Company has received an order for tobacco-free nicotine pouches from the American company Turning Point Brands, Louisville, USA. The order is worth approximately SEK 1.9 million and the first products are expected to be delivered during the first...

Enorama Pharma receives order for tobacco-free nicotine pouches

Enorama Pharma announces that the Company has received an order for tobacco-free nicotine pouches from the American company Good Work Tech, New York, USA. The order is worth approximately SEK 1.1 million and the first products are expected to be delivered during the first half of...